Antimania in canine leishmaniosis

Antimania is a prescription-only injectable veterinary medicine. Assessment, administration and monitoring are the veterinarian’s responsibility.

Prescription-only medicine

Meglumine antimoniate is used in canine leishmaniosis according to its authorised indication. This page does not publish injection protocols or adaptations for home use.

Diagnosis and staging precede every treatment decision.

Contraindications and monitoring

Kidney, liver and heart function are relevant factors stated in the summary of product characteristics. Decisions in special circumstances are solely the veterinarian’s responsibility and require checks.

Reactions or deterioration must be reported without changing treatment independently.

Prevention and follow-up

Treatment does not replace protection against sand flies or ongoing checks. The overall plan follows staging, clinical response and current guidelines.

Sources and document updates

This information is general and does not replace diagnosis, prescription or instructions from a veterinarian. For a medicine, the summary of product characteristics or package leaflet for the specific presentation is authoritative.

• Union Product Database — Antimania: official medicine information (accessed 24/07/2026)
• LeishVet — LeishVet factsheets (accessed 24/07/2026)
• ESCCAP — GL5 - Vector-borne diseases in dogs and cats (accessed 24/07/2026)

Editorial transparency: sources are provided to allow the documents to be checked. Professional review is only declared after genuine approval by a qualified, identifiable person.